Rhenman & Partners Asset Management Ab Johnson & Johnson Transaction History

Rhenman & Partners Asset Management Ab

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$168.19 - $186.01 $2.19 Million - $2.42 Million	-13,000 Reduced 11.5%	100,000 $17.8 Million
Q1 2022 May 13, 2022	SELL	$158.14 - $179.59 $22.1 Million - $25.1 Million	-140,000 Reduced 55.34%	113,000 $20 Million
Q4 2021 Feb 11, 2022	SELL	$155.93 - $173.01 $2.65 Million - $2.94 Million	-17,000 Reduced 6.3%	253,000 $43.6 Million
Q3 2021 Nov 12, 2021	BUY	$161.5 - $179.47 $31.5 Million - $35 Million	195,000 Added 260.0%	270,000 $43.6 Million
Q2 2021 Aug 13, 2021	SELL	$159.48 - $171.07 $39.9 Million - $42.8 Million	-250,000 Reduced 76.92%	75,000 $12.4 Million
Q1 2021 May 14, 2021	BUY	$153.07 - $170.48 $32.1 Million - $35.8 Million	210,000 Added 182.61%	325,000 $53.4 Million
Q4 2020 Jan 19, 2021	BUY	$137.11 - $157.38 $15.8 Million - $18.1 Million	115,000 New	115,000 $18.1 Million
Q3 2018 Oct 03, 2018	SELL	$121.58 - $142.88 $7.29 Million - $8.57 Million	-60,000 Closed	0 $0
Q2 2018 Jul 20, 2018	BUY	$119.4 - $131.76 $7.16 Million - $7.91 Million	60,000 New	60,000 $7.28 Million

4,161

1.69B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $434B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.